Hepion Pharmaceuticals In... (HEPA)

AI Score

Unlock

0.44

-0.04 (-9.05%)

At close: Apr 04, 2025, 10:50 AM

Hepion Pharmaceuticals Balance Sheet Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014	Jun 30, 2013
Cash & Equivalents	14.79M	51.19M	91.35M	40.73M	13.92M	2.83M	5.95M	12.98M	7.4M	4.56M	1.82M	86.72K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	-564.84K	-619.38K	-731.3K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	364.19K	426.17K	583.33K	285.1K	306.88K	127.79K	3.26M	63.18K	69.95K	51.34K	4.2K	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	17.49M	56.5M	97.45M	42.63M	14.39M	2.97M	6.06M	13.19M	7.89M	5.24M	1.98M	86.72K
Property-Plant & Equipment	242.37K	132.21K	456.46K	664.93K	855.08K	32.43K	56.59K	67.56K	80.85K	81.44K	14.53K	n/a
Goodwill & Intangibles	n/a	3.19M	5.06M	5.06M	5.06M	5.06M	1.87M	5.06M	5.06M	n/a	n/a	n/a
Total Long-Term Assets	606.56K	3.75M	6.1M	6.01M	6.22M	5.22M	5.19M	5.19M	5.21M	132.78K	18.73K	n/a
Total Assets	18.09M	60.24M	103.55M	48.65M	20.61M	8.19M	11.25M	18.38M	13.11M	5.38M	2M	86.72K
Account Payables	2.35M	2.67M	2.45M	3.72M	491.56K	748.43K	1.56M	1.63M	4.25M	1.48M	243.9K	3.62K
Deferred Revenue	n/a	4.8M	2.51M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-100.33K
Short-Term Debt	n/a	53.61K	266.65K	279.83K	266.7K	1.44M	n/a	n/a	n/a	n/a	n/a	100.33K
Other Current Liabilities	386K	2.22M	4.36M	229.04K	238.26K	n/a	0.00	n/a	n/a	n/a	6.93K	n/a
Total Current Liabilities	5.29M	7.89M	8.21M	4.66M	1.61M	2.85M	2.6M	2.94M	5.08M	1.94M	458.74K	227.21K
Long-Term Debt	n/a	n/a	n/a	176.59K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	5.43M	2.09M	1.89M	2.58M	2.44M	3M	4.05M	5.11M	5.44M	n/a	4.48M	n/a
Total Long-Term Liabilities	5.52M	2.5M	2.35M	3.46M	3.39M	3.36M	4.95M	6.38M	6.71M	n/a	4.48M	n/a
Total Liabilities	10.81M	10.39M	10.56M	8.12M	4.99M	6.21M	7.55M	9.33M	11.79M	1.94M	4.93M	227.21K
Total Debt	209.02K	53.61K	316.99K	752.17K	807.45K	1.44M	n/a	n/a	10.41K	n/a	n/a	100.33K
Common Stock	482.00	7.62K	7.62K	3.2K	375.00	25.00	7.83K	7.57K	3.22K	2.23K	1.85K	900.00
Retained Earnings	-224.63M	-175.7M	-133.5M	-104.11M	-83.75M	-76.46M	-67.01M	-59.5M	-44.61M	-27.61M	-5.42M	-140.5K
Comprehensive Income	-78.78K	-90.17K	0.00	-0.00	n/a	n/a	-0.00	n/a	n/a	n/a	0.00	-900
Shareholders Equity	7.28M	49.86M	93M	40.52M	15.62M	1.98M	3.7M	9.06M	1.32M	3.44M	-2.93M	-140.5K
Total Investments	n/a	-564.84K	-619.38K	-731.3K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a